ROUND TABLE · 2018

2018 – Pharmaco economics: Towards a viable model of partnerships

Pharmacoeconomics : Towards a viable model of partnerships

2018-pharmacoeconomics-0a752cdb

About this session

Pharmacoeconomics : Towards a viable model of partnerships

Challenges and prospects of performance contracts.

Importance of knowing the clinical and economic evidence At all levels of the decision process (micro - meso - macro) At any time of the development of innovation (pre and post AMM)

The environment & framework for adopting a risk-sharing agreement

Attending experts

Sandrine-baffert-1c0b2ee5

Sandrine Baffert,

Healthcare Economiste, CMKA

Audience

  • Director General of ANPP, Mme Watfa Benayad Cherif
  • Director General of Social Security, Djaouad Bourkaib &Dr. Mohamed Lamine Ghanem
  • President of the Healthcare commission, Senate, Pr. Louisa Chachoua
  • Advisors from the MOH Mme Kraiba, Mme Benkedadra, M. Bouali
  • Lyes Rahal, Director General of INSP
  • Representatives from PCH, IPA, Medecite université, Ministry of Industry